SUMMARY
This study sought to investigate the effects of mechanical unloading on myocardial energetics and the metabolic perturbation of heart failure (HF) in an effort to identify potential new therapeutic targets that could enhance the unloading-induced cardiac recovery. The authors prospectively examined paired human myocardial tissue procured from 31 advanced HF patients at left ventricular assist device (LVAD) implant and at heart transplant plus tissue from 11 normal donors. They identified increased post-LVAD glycolytic metabolites without a coordinate increase in early, tricarboxylic acid (TCA) cycle intermediates. The increased pyruvate was not directed toward the mitochondria and the TCA cycle for complete oxidation, but instead, was mainly converted to cytosolic lactate. Increased nucleotide concentrations were present, potentially indicating increased flux through the pentose phosphate pathway. Evaluation of mitochondrial function and structure revealed a lack of post-LVAD improvement in mitochondrial oxidative functional capacity, mitochondrial volume density, and deoxyribonucleic acid content. Finally, post-LVAD unloading, amino acid levels were found to be increased and could represent a compensatory mechanism and an alternative energy source that could fuel the TCA cycle by anaplerosis. In summary, the authors report evidence that LVAD unloading induces glycolysis in concert with pyruvate mitochondrial oxidation mismatch, most likely as a result of persistent mitochondrial dysfunction. These findings H eart failure (HF) is a global epidemic with a prevalence of 2% to 3% in the United States and Europe, and it is a huge cost to the health care systems (1) . Despite advances in pharmacological therapies, implantable defibrillators, cardiac resynchronization, and stem cell/regenerative therapies, patients with advanced HF experience mortality rates in excess of 50% per year (1) .
Mechanical unloading through a left ventricular assist device (LVAD) is a therapeutic intervention that leads to substantial improvement in cardiac function in a subgroup of patients with end-stage HF (2, 3) .
The functional response of the failing human heart to mechanical unloading is not an "all or none" phenomenon, and the mechanisms guiding this response are the subject of investigation (4) . On the basis of previous human and animal studies, left ventricular (LV) pressure and volume overload alters metabolic substrate utilization, decreases mitochondrial function, and reduces energy production in the failing heart (5) . Mechanical unloading has the potential to reverse these deleterious metabolic adaptations of the failing heart and even activate cellular pathways of cardioprotection and cardiac repair (6, 7) . On the other hand, excessive or prolonged unloading could decrease myocardial energy demand, leading to myocardial hibernation and suppression of cellular repair. 
LVAD Unloading and Cardiac Metabolism
We have previously shown that LVAD unloading may lead to hypertrophy regression through disruption of the equilibrium between protein synthesis and degradation (8) . This altered equilibrium could also affect the intracellular pool of amino acids. An elevation in amino acid levels could provide alternative building blocks for protein synthesis and could supplement the Krebs tricarboxylic acid (TCA) cycle with intermediates through anaplerosis. Upregulation of anaplerosis has previously been shown to play a cardioprotective role in the failing heart (9) .
In this study we investigate how the mechanical unloading induced by LVAD affects the bioenergetic adaptation and metabolic perturbation in the chronically failing human heart. MITOCHONDRIAL RESPIRATORY FLUX. Mitochondrial respiration was assessed as previously described (12) .
METHODS
For details, please see the Supplemental Appendix. STATISTICAL ANALYSIS. Statistical analysis was performed as previously described (8, 13) . Values are expressed as mean AE SEM. The paired samples Student t test was used for comparisons between preand post-LVAD unloading. The independent samples t test was used for comparisons between the failing and the normal hearts. Prism 6 (GraphPad, San Diego, California) was used for statistical analysis. Significance was determined as p < 0.05.
RESULTS
STUDY POPULATION AND HEMODYNAMIC DATA. The clinical characteristics of the study population are presented in Table 1 . Hemodynamic data before and 2 months after LVAD implantation are shown in Table 2 . We did not have enough subjects to adequately explore whether the subgroup of patients with significant myocardial functional improvement after LVAD unloading (i.e., cardiac recovery "responders") exhibited improved mitochondrial oxidative capacity and increased mitochondrial density and DNA content to a greater extent than the cardiac recovery "nonresponders." However, our limited data did show a trend toward greater mitochondrial improvement in the patients with the greatest favorable The failing heart is characterized by impaired mitochondrial biogenesis, as well as structural and functional mitochondrial defects (21, 22 In our study, we also found evidence indicating a post-LVAD glycolysis-pyruvate oxidation mismatch.
Although glycolysis was induced after LVAD unloading leading to increased pyruvate production, the latter was not directed into the TCA cycle and the mitochondria for complete oxidation. Instead, we provided evidence that the pyruvate was converted into lactic acid in the cytoplasm. This phenomenon might be explained by the decreased energy demands of the unloaded heart that makes glycolysis a sufficient energy source to cover ATP requirements. Also, because intramitochondrial glucose oxidation is the major source for reactive oxygen species production in the respiratory chain, the observed glycolysispyruvate oxidation mismatch could represent a protective mechanism leading to oxidative stress reduction. (Figure 7) . In addition to their putative role in protein synthesis, we believe that amino acids are also used as metabolic substrates in TCA cycle (37, 38) . 
